can glp 1 cause sibo being on a GLP-1 medication SIBO? Anti-obesity drugs for the gastroenterologist

Methods In this study, we investigated the add-on potential of the dual amylin and calcitonin receptor agonist (DACRA) KBP-089 in combination with the GLP-1 receptor agonist liraglutide as obesity treatment in high-fat diet (HFD) fed rats

Given spironolactone has endocrine effects, it is plausible that it could increase the risk of hormonally dependent cancers, such as breast, ovarian, or endometrial cancers

Looking forward to this presentation at Formulation & Delivery in Berlin: Lonza Capsugel To view or add a comment, sign in A tablet may look simple

In the no-gap trials, the background noise was a 70-dB SPL pure tone at 16 kHz, followed by a 50-ms white noise burst at 110 dB SPL to elicit the startle response

It is about eating in a way that supports your metabolism, digestion, blood sugar, bowel movements, and long-term health